Proteomics

Dataset Information

0

Identification of DHC2 associated nuclear proteins in DHC2 knockdown U87 cells


ABSTRACT: The acquisition of temozolomide resistance is a major clinical challenge for glioblastoma treatment. Chemoresistance in glioblastoma is largely attributed to repair of temozolomide-induced DNA lesions by MGMT. However, many MGMT-negative glioblastomas are still resistant to temozolomide, and the underlying molecular mechanisms remain unclear. We found that DHC2 was highly expressed in MGMT-negative recurrent glioblastoma specimens and its expression strongly correlated to poor progression-free survival in MGMT-negative glioblastoma patients. In vivo and in vitro, silencing DHC2 enhanced temozolomide-induced DNA damage and significantly improved the efficiency of temozolomide treatment in MGMT-negative glioblastoma cells. It is known DHC2 is related to intracellular cargo transportation. To identify the potential interacted “cargo” DHC2 transported and explore the underlying molecular mechanisms of DHC2-midiated DNA damage repair, we performed subcellular proteomic and bioinformatic analyses.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture, Glioblast (sensu Nematoda And Protostomia)

DISEASE(S): Brain Glioblastoma Multiforme

SUBMITTER: Yawei Liu  

LAB HEAD: Yawei Liu

PROVIDER: PXD012032 | Pride | 2022-02-28

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
P16190_KN_D.raw Raw
P16190_KN_D_160702061954.raw Raw
P16190_KN_D_160702085343.raw Raw
P16190_KN_T.raw Raw
P16190_KN_T_160701223841.raw Raw
Items per page:
1 - 5 of 11

Similar Datasets

2019-08-20 | PXD007193 | Pride
2020-04-02 | GSE129476 | GEO
2022-12-21 | GSE217515 | GEO
| 2272487 | ecrin-mdr-crc
2012-09-11 | GSE40776 | GEO
2018-07-13 | GSE113816 | GEO
2012-09-11 | E-GEOD-40776 | biostudies-arrayexpress
2018-10-23 | PXD007759 | Pride
2022-08-20 | GSE207426 | GEO
2011-01-08 | E-TABM-890 | biostudies-arrayexpress